ClinicalTrials.Veeva

Menu

Glucose Tolerance and Prevention of Diabetes Mellitus Type 2 by Polyherbal Formulation (Phase-1)

I

Islamia University of Bahawalpur

Status

Completed

Conditions

Diabetes Mellitus
Pre Diabetes

Treatments

Dietary Supplement: Polyherbal formulation

Study type

Observational

Funder types

Other

Identifiers

NCT03884920
Hashmi5767

Details and patient eligibility

About

Primary protocol to this study is to develop a natural remedy to prevent diabetes mellitus in pre-diabetic state and elaborate the effectiveness of polyherbal formulation for carrying out Phase-II, III and IV. It also aimed at to see the level of difference of glucose tolerance and impaired fasting glucose and impaired glucose tolerance between pre-diabetic and diabetic to evaluate the potential benefit for treatment of insulin resistance and sensitivity. To see the for prevention of Diabetes Mellitus (DM) and stopping / delaying the onset of DM.

Full description

This study is a clinical trial study to evaluate the potential of prevention in pre-diabetics and to prevent onset of diabetes mellitus. For this purpose, volunteers will be enrolled in the study by observing the Helsinki Declaration for clinical trials.

volunteers will be screened for the impaired glucose tolerance or impaired fasting glucose or at risk to develop diabetes mellitus type 2.

On screening, pre-diabetics and early onset diabetics with no previous history of treatment etc will be grouped into A and B.

Biochemical evaluations will be carried out at base line and followed by three weeks intervention and evaluation of biomarkers and at sixth week for further evaluation.

Collected data will be evaluated for primary out comes and secondary out come. statistical analysis will be done. One year followup of participants was conducted.

Enrollment

57 patients

Sex

All

Ages

18 to 59 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: 18-59
  • Impaired Fasting Glucose (100-125mg/dl)
  • Impaired Glucose Tolerance (140-199mg/dl) 2h-75gm OGTT
  • History of Diabetes in first degree relation with one condition
  • At high risk with BMI > 35%
  • Early onset diabetic / accidental on screening (glucose >200mg/dl)

Exclusion criteria

  • on renal dialysis;
  • an acute or terminal illness or serious mental illness;
  • history of recent coronary event within the last 12 months;
  • a recent history of acute medical problem or admission to hospital;
  • any other severe medical conditions that need intervention / treatment
  • has poor short-term prognosis (expected death in <2 years);
  • is planning to travel for longer than 6 weeks during the 6-week intervention period; or
  • is with compromised liver / kidney / cardiac function
  • older patients of DM taking any form of medication / intervention

Trial design

57 participants in 3 patient groups

Group A Pre-diabetic placebo
Description:
Group of pre-diabetics receiving placebo BD for six weeks
Group B Pre-diabetic test
Description:
Group of Pre-diabetic receiving polyherbal / test candidate 900mg in two divided doses for six weeks
Treatment:
Dietary Supplement: Polyherbal formulation
Group C Diabetic test
Description:
Early onset of Diabetes mellitus receiving polyherbal formulation 1800mg in two divided doses for six weeks
Treatment:
Dietary Supplement: Polyherbal formulation

Trial documents
1

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems